147 related articles for article (PubMed ID: 17685031)
1. [Primary aldosteronism with ventricular fibrillation: a case report].
Furukawa A; Komatsu R; Itoh A; Nakamura T; Yagishita D; Yunoki K; Ohashi J; Shirai N; Abe Y; Nakagawa E; Naruko T; Haze K
J Cardiol; 2007 Jul; 50(1):77-82. PubMed ID: 17685031
[TBL] [Abstract][Full Text] [Related]
2. Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism.
Abdo A; Bebb RA; Wilkins GE
Can J Cardiol; 1999 Mar; 15(3):347-8. PubMed ID: 10202199
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation and recurrent ventricular fibrillation during hypokalemia in Brugada syndrome.
Notarstefano P; Pratola C; Toselli T; Ferrari R
Pacing Clin Electrophysiol; 2005 Dec; 28(12):1350-3. PubMed ID: 16403168
[TBL] [Abstract][Full Text] [Related]
4. Life-threatening arrhythmia caused by primary aldosteronism.
Zelinka T; Holaj R; Petrák O; Strauch B; Kasalický M; Hanus T; Melenovský V; Vancura V; Bürgelová M; Widimský J
Med Sci Monit; 2009 Dec; 15(12):CS174-7. PubMed ID: 19946238
[TBL] [Abstract][Full Text] [Related]
5. Ventricular fibrillation as the first manifestation of primary hyperaldosteronism.
Delgado Y; Quesada E; Pérez Arzola M; Bredy R
Bol Asoc Med P R; 2006; 98(4):258-62. PubMed ID: 19610566
[TBL] [Abstract][Full Text] [Related]
6. Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia.
Araki T; Konno T; Itoh H; Ino H; Shimizu M
Circ J; 2003 Jan; 67(1):93-5. PubMed ID: 12520160
[TBL] [Abstract][Full Text] [Related]
7. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
[TBL] [Abstract][Full Text] [Related]
8. [Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review].
Kukla P; Petkow-Dimitrow P; Jastrzebski M; Bednarek J; Lelakowski J; Bryniarski L
Kardiol Pol; 2009 Jul; 67(7):774-80; discussion 781. PubMed ID: 19650001
[TBL] [Abstract][Full Text] [Related]
9. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
10. [Recovery from fatal ventricular fibrillation after immediate application of percutaneous cardiopulmonary support].
Matsunari Y; Imanaka H; Takeuchi M; Tachibana K; Takauchi Y
Masui; 2004 Jul; 53(7):795-8. PubMed ID: 15298250
[TBL] [Abstract][Full Text] [Related]
11. A case of vagally mediated idiopathic ventricular fibrillation.
Kataoka M; Takatsuki S; Tanimoto K; Akaishi M; Ogawa S; Mitamura H
Nat Clin Pract Cardiovasc Med; 2008 Feb; 5(2):111-5. PubMed ID: 18223543
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic ventricular arrhythmia in a young man: a case report.
Choo WK; Aronica G
Emerg Med J; 2009 Sep; 26(9):681-2. PubMed ID: 19700598
[TBL] [Abstract][Full Text] [Related]
13. [Ablation of a catecholaminergic polymorphic VT and VF originating from Purkinje fibers--a case report].
Szumowski L; Walczak F; Przybylski A; Maryniak A; Szufladowicz E; Derejko P; Bieganowska K; Bodalski R; Orczykowski M; Sterliński M; Miszczak-Knecht M; Szwed A
Kardiol Pol; 2007 Mar; 65(3):319-26. PubMed ID: 17436165
[TBL] [Abstract][Full Text] [Related]
14. [Successful defibrillation by disconnection of superior vena cava electrode for high defibrillation threshold: a case report].
Matsushita K; Ishikawa T; Sumita S; Kobayashi T; Kawasaki N; Matsumoto K; Taima M; Uchino K; Kimura K; Umemura S
J Cardiol; 2005 Jan; 45(1):27-32. PubMed ID: 15700927
[TBL] [Abstract][Full Text] [Related]
15. Plasma potassium, serum magnesium and ventricular fibrillation: a prospective study.
Higham PD; Adams PC; Murray A; Campbell RW
Q J Med; 1993 Sep; 86(9):609-17. PubMed ID: 8255976
[TBL] [Abstract][Full Text] [Related]
16. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia?
Sweeney MO; Ruetz LL; Belk P; Mullen TJ; Johnson JW; Sheldon T
J Am Coll Cardiol; 2007 Aug; 50(7):614-22. PubMed ID: 17692746
[TBL] [Abstract][Full Text] [Related]
17. Out of the guidelines: should an intracardiac defibrillator be implanted in patients with recurrent early ventricular fibrillation due to recurrent acute myocardial infarction?
Faggiano P; Pulcini E; Curnis A; Vizzardi E; Cas LD
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):371-3. PubMed ID: 17443105
[TBL] [Abstract][Full Text] [Related]
18. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators.
Anthony R; Daubert JP; Zareba W; Andrews ML; McNitt S; Levine E; Huang DT; Hall WJ; Moss AJ;
Pacing Clin Electrophysiol; 2008 Feb; 31(2):144-50. PubMed ID: 18233965
[TBL] [Abstract][Full Text] [Related]
20. Sibutramine-associated QT interval prolongation and cardiac arrest.
Ernest D; Gershenzon A; Corallo CE; Nagappan R
Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
